K D Tutsch

Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

Russell F. Jacoby, D. J. Marshall, Michael A. Newton et al. · PubMed · 1996 · 295 citations

Medicine, Oncology, Pharmacology +13

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

Howard H. Bailey, Ríona Mulcahy, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 186 citations

Medicine, Oncology, Pharmacology +11

Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan

Howard H. Bailey, Gregory H. Ripple, K D Tutsch et al. · JNCI Journal of the National Cancer Institute · 1997 · 165 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

Joan H. Schiller, B. Storer, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 136 citations

Medicine, Oncology, Pharmacology +14

Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

Jean L. Grem, K D Tutsch, Kris Simon et al. · PubMed · 1987 · 102 citations

Medicine, Pharmacology, Pharmacotherapy +12